Low dose ketamine produces antidepressant actions in MDD and TRD patients.
The cellular mechanisms underlying ketamine's antidepressant actions remain unclear.
Two mechanistic hypotheses to explain how ketamine's actions are initiated are reviewed here.
These two hypotheses offer a framework for studying ketamine's effects as an anti-depressant.